These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 13671070)

  • 1. [Significance of insulin-inactivating properties of the liver (insulinase) in the mechanism of action of antidiabetic sulfonamides].
    LEITES SM; SMIRNOV NP
    Biull Eksp Biol Med; 1959 Jun; 47(6):58-62. PubMed ID: 13671070
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of the liver in the mechanism of hypoglycemic action of antidiabetic sulfonamides].
    LEITES SM; SMIRNOV NP
    Biull Eksp Biol Med; 1958 Sep; 46(9):53-6. PubMed ID: 13607530
    [No Abstract]   [Full Text] [Related]  

  • 3. Dynamical influence of Cordyceps sinensis on the activity of hepatic insulinase of experimental liver cirrhosis.
    Zhang X; Liu YK; Shen W; Shen DM
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):99-101. PubMed ID: 14969848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological properties of the extract and some isolated compounds of Clausena lansium stem bark: anti-trichomonal, antidiabetic, anti-inflammatory, hepatoprotective and antioxidant effects.
    Adebajo AC; Iwalewa EO; Obuotor EM; Ibikunle GF; Omisore NO; Adewunmi CO; Obaparusi OO; Klaes M; Adetogun GE; Schmidt TJ; Verspohl EJ
    J Ethnopharmacol; 2009 Feb; 122(1):10-9. PubMed ID: 19095054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the role of liver insulinase in the mechanism of action of peroral antidiabetic agents].
    LEITES SM
    Patol Fiziol Eksp Ter; 1962; 6():76-9. PubMed ID: 13929468
    [No Abstract]   [Full Text] [Related]  

  • 6. [Insulinase and its inhibition by hypoglycemic sulfonamides; data on insulin sensitivity during tolbutamide therapy].
    MARIGO S; PANELLI G
    Arch Sci Med (Torino); 1958 Jun; 105(6):587-609. PubMed ID: 13560210
    [No Abstract]   [Full Text] [Related]  

  • 7. [Insulinase activity in the liver in acute fatty degeneration; its relation to the type and gravity of liver lesions].
    COVA N
    Biol Lat; 1957; 10(3):439-49. PubMed ID: 13471620
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents.
    Goodarzi MO; Bryer-Ash M
    Diabetes Obes Metab; 2005 Nov; 7(6):654-65. PubMed ID: 16219009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research on insulinase. II. The nature of hepatic insulinase].
    DE BARBIERI A; GRASSI M
    Farmaco Sci Tec; 1951; 6(2):170-81. PubMed ID: 14849596
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production.
    Inoue H; Ogawa W; Asakawa A; Okamoto Y; Nishizawa A; Matsumoto M; Teshigawara K; Matsuki Y; Watanabe E; Hiramatsu R; Notohara K; Katayose K; Okamura H; Kahn CR; Noda T; Takeda K; Akira S; Inui A; Kasuga M
    Cell Metab; 2006 Apr; 3(4):267-75. PubMed ID: 16581004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action.
    Bard-Chapeau EA; Hevener AL; Long S; Zhang EE; Olefsky JM; Feng GS
    Nat Med; 2005 May; 11(5):567-71. PubMed ID: 15821749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypoglycemic and antidiabetic sulfonamides. II. Study of their mechanism of action in normal and diabetic subjects].
    LOUBATIERES A
    Presse Med (1893); 1958 Jul; 66(53):1229-32. PubMed ID: 13567572
    [No Abstract]   [Full Text] [Related]  

  • 14. Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice.
    Mueller AS; Pallauf J
    J Nutr Biochem; 2006 Aug; 17(8):548-60. PubMed ID: 16443359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic activity of aqueous leaf extract of Annona squamosa in streptozotocin-nicotinamide type 2 diabetic rats.
    Shirwaikar A; Rajendran K; Dinesh Kumar C; Bodla R
    J Ethnopharmacol; 2004 Mar; 91(1):171-5. PubMed ID: 15036485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin-inactivating property of the liver in conditions of disturbed insulin supply].
    SHALIAPINA VG
    Probl Endokrinol Gormonoter; 1963; 9():51-4. PubMed ID: 13988403
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice.
    Yakar S; Setser J; Zhao H; Stannard B; Haluzik M; Glatt V; Bouxsein ML; Kopchick JJ; LeRoith D
    J Clin Invest; 2004 Jan; 113(1):96-105. PubMed ID: 14702113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis.
    Buettner R; Ottinger I; Schölmerich J; Bollheimer LC
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E828-33. PubMed ID: 14722026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity.
    Uno K; Katagiri H; Yamada T; Ishigaki Y; Ogihara T; Imai J; Hasegawa Y; Gao J; Kaneko K; Iwasaki H; Ishihara H; Sasano H; Inukai K; Mizuguchi H; Asano T; Shiota M; Nakazato M; Oka Y
    Science; 2006 Jun; 312(5780):1656-9. PubMed ID: 16778057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY; Pan JQ; Lv JH
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.